SAN FRANCISCO, November 20, 2018 /PRNewswire/ --
The global injection pens/injectable pens/pen injectors
market is expected to reach USD
67.9 billion by 2025, according to a new report by Grand
View Research, Inc., registering a 9.4% CAGR during the forecast
period. High demand for these devices for management of various
chronic as well as acute diseases and increasing awareness in
developing regions are key factors expected to drive the
market.
(Logo:
https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg
)
Injectable pens have witnessed significant success in improving
patient convenience during management of chronic disease, a process
that might include administering intermittent injections. These
devices are more convenient and affordable than other delivery
systems. Ongoing studies on the same to assess their applications
in management of other diseases, including but not limited to
Hepatitis C and cancer, is expected to ensure swift market growth
through 2025.
Browse full research report with TOC on
"Injection Pens Market Size, Share & Trends Analysis
Report By Product (Disposable, Reusable), By Dosage (Fixed,
Variable), By Application, And Segment Forecasts, 2018 -
2025" at:
https://www.grandviewresearch.com/industry-analysis/injection-pens-market
Further Key Findings From the Report Suggest:
- Rising incidence of diseases such as diabetes and arthritis is
primarily boosting market growth
- Increase in government healthcare expenditure and availability
of favorable healthcare insurance policies in developed as well as
developing countries is driving the market
- By product, reusable injectable pens are the largest and
fastest growing segment owing to the advantages associated with
them such as cost effectiveness and patient convenience.
Commercially available reusable injectable pens mainly include
Novopen, Luxura, Berlipen, AllStar, NovoRapid, basalgar, Bydureon,
Epipen and Genotropin
- By dosage, variable dosage is the fastest growing segment. Some
of the customizable variable pens are UnoPen, ServoPen and Ypsopen
by Ypsomed, Madie by SHL Group, and Evo pen by Copernicus
- North America dominates the
market, followed by Europe.
Technological advancements and increase in incidence of
osteoporosis, arthritis, and anaphylaxis are factors that can be
attributable to its largest market share
- Asia Pacific is expected to be
the fastest growing region over the forecast period. Better
accessibility to healthcare, coupled with constantly increasing
healthcare expenditure in the region, is fueling market growth
- China is one of the most
lucrative markets with tremendous growth opportunities for global
as well as local players. This is owing to favorable factors such
as availability of labor and raw materials at significantly lower
prices as compared to other regions
- Key players in the market include Owen Mumford Ltd.;
GlaxoSmithKline plc; Eli Lilly and Company; Mylan N.V.;
AstraZeneca; Novo Nordisk; Sanofi; and Sandoz Inc.
Browse related reports by Grand View Research:
- Reprocessed Medical Devices Market - The global
reprocessed medical devices market size was estimated at
USD 1.64 billion in 2016 and is
anticipated to grow at a CAGR of 20.6% over the forecast
period.
- Electroceuticals/Bioelectric Medicine Market -
The global electroceuticals/bioelectric medicine market size was
estimated at USD 17.2 billion in
2016.
- Biosensors Market - The global biosensors market
size was valued at USD 15.6 billion
in 2016 and is expected grow at a CAGR of 7.9% during the forecast
period.
- Bone Densitometers Market - The global bone
densitometers market size was estimated at USD 893.7 million in 2016 and is expected to grow
at a CAGR of 3.9% over the coming years.
Grand View Research has segmented the global injection pens
market on the basis of product, dosage, application, and
region:
- Injection Pens Product Outlook (Revenue, USD Billion, 2014 -
2025)
- Injection Pens Dosage Outlook (Revenue, USD Billion, 2014 -
2025)
- Injection Pens Application Outlook (Revenue, USD Billion,
2014 - 2025)
- Diabetes
- Anaphylaxis
- Osteoporosis
- Growth hormone deficiency
- Arthritis
- Others
- Injection Pens Regional Outlook (Revenue, USD Billion, 2014
- 2025)
- North America
- Europe
- Germany
- U.K.
- Greece
- Denmark
- Spain
- Norway
- Belgium
- Austria
- Asia Pacific
- Japan
- China
- India
- Thailand
- Australia
- Singapore
- Malaysia
- Sri Lanka
- Bangladesh
- South Korea
- Latin America
- MEA
- UAE
- Saudi Arabia
- South Africa
- Qatar
- Kuwait
Explore the BI enabled intuitive market research
database, Grand View Compass, by Grand View Research,
Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company
provides syndicated research reports, customized research reports,
and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant
and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com